347 related articles for article (PubMed ID: 27936464)
41. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
Steele N; Finn P; Brown R; Plumb JA
Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094
[TBL] [Abstract][Full Text] [Related]
42. Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.
Kuang Y; El-Khoueiry A; Taverna P; Ljungman M; Neamati N
Mol Oncol; 2015 Nov; 9(9):1799-814. PubMed ID: 26160429
[TBL] [Abstract][Full Text] [Related]
43. Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer.
Steinemann G; Dittmer A; Schmidt J; Josuttis D; Fähling M; Biersack B; Beindorff N; Jolante Koziolek E; Schobert R; Brenner W; Müller T; Nitzsche B; Höpfner M
Mol Oncol; 2019 Dec; 13(12):2679-2696. PubMed ID: 31583820
[TBL] [Abstract][Full Text] [Related]
44. MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.
Rossi M; Colecchia D; Ilardi G; Acunzo M; Nigita G; Sasdelli F; Celetti A; Strambi A; Staibano S; Croce CM; Chiariello M
Oncotarget; 2016 Apr; 7(15):20981-98. PubMed ID: 26988910
[TBL] [Abstract][Full Text] [Related]
45. [Analysis of gene expression of human tumor cells in testicular tumor].
Niclas C; Sparwasser C
Urologe A; 2007 Sep; 46(9):1185. PubMed ID: 17690861
[No Abstract] [Full Text] [Related]
46. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.
Blomberg Jensen M; Jørgensen A; Nielsen JE; Steinmeyer A; Leffers H; Juul A; Rajpert-De Meyts E
Neoplasia; 2012 Oct; 14(10):952-63. PubMed ID: 23097629
[TBL] [Abstract][Full Text] [Related]
47. Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
Hassler MR; Klisaroska A; Kollmann K; Steiner I; Bilban M; Schiefer AI; Sexl V; Egger G
Biochimie; 2012 Nov; 94(11):2297-307. PubMed ID: 22687603
[TBL] [Abstract][Full Text] [Related]
48. Epigenetics: a way to understand the origin and biology of testicular germ cell tumors.
Okamoto K
Int J Urol; 2012 Jun; 19(6):504-11. PubMed ID: 22375557
[TBL] [Abstract][Full Text] [Related]
49. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
[TBL] [Abstract][Full Text] [Related]
50. Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity.
Awuah SG; Riddell IA; Lippard SJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):950-955. PubMed ID: 28096358
[TBL] [Abstract][Full Text] [Related]
51. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
[TBL] [Abstract][Full Text] [Related]
52. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours.
di Pietro A; Vries EG; Gietema JA; Spierings DC; de Jong S
Int J Biochem Cell Biol; 2005 Dec; 37(12):2437-56. PubMed ID: 16099193
[TBL] [Abstract][Full Text] [Related]
53. Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
Lengert AVH; Pereira LDNB; Cabral ERM; Gomes INF; Jesus LM; Gonçalves MFS; Rocha AOD; Tassinari TA; Silva LSD; Laus AC; Vidal DO; Pinto MT; Reis RM; Lopes LF
Front Biosci (Landmark Ed); 2022 Aug; 27(8):245. PubMed ID: 36042160
[TBL] [Abstract][Full Text] [Related]
54. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
55. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors.
Killian JK; Dorssers LC; Trabert B; Gillis AJ; Cook MB; Wang Y; Waterfall JJ; Stevenson H; Smith WI; Noyes N; Retnakumar P; Stoop JH; Oosterhuis JW; Meltzer PS; McGlynn KA; Looijenga LH
Genome Res; 2016 Nov; 26(11):1490-1504. PubMed ID: 27803193
[TBL] [Abstract][Full Text] [Related]
56. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
[TBL] [Abstract][Full Text] [Related]
57. Up-regulation of DNA-methyltransferase 3A expression is associated with hypomethylation of intron 25 in human testicular germ cell tumors.
Ishii T; Kohu K; Yamada S; Ishidoya S; Kanto S; Fuji H; Moriya T; Satake M; Arai Y
Tohoku J Exp Med; 2007 Jun; 212(2):177-90. PubMed ID: 17548962
[TBL] [Abstract][Full Text] [Related]
58. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations.
Oing C; Skowron MA; Bokemeyer C; Nettersheim D
Andrology; 2019 Jul; 7(4):487-497. PubMed ID: 30924611
[TBL] [Abstract][Full Text] [Related]
59. Phase II study of everolimus in refractory testicular germ cell tumors.
Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
[TBL] [Abstract][Full Text] [Related]
60. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
